Showing results (121-130 of 197) with videos related to
Sort By:
Pageof 20
Archives of Microbiology|January 1, 1993
Effect of novel compound, 1-methyl-1-piperidino methane sulfonate (MPMS), on the osmoprotectant activity of glycine betaine, choline and L-proline in Escherichia coliC M Kunin, H H Tong, D D Miller, et al.Reviews of Infectious Diseases|September 1, 1991
Role of antimicrobial pharmacokinetics and pharmacodynamics in surgical prophylaxisJ Redington, S C Ebert, W A CraigInfection|January 1, 1980
Tissue binding of antimicrobial agents in vitro: a critical study focusing on the concentration of the tissue homogenate usedA Gerber, N Frimodt-Möller, W A CraigThe Journal of Antimicrobial Chemotherapy|May 1, 1991
Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infectionsW A Craig, J Redington, S C EbertInternational Journal of Immunopharmacology|February 1, 1992
Modulation of tumor necrosis factor release from alveolar macrophages treated with pentamidine isethionateE Corsini, W A Craig, G J RosenthalThe Journal of Antimicrobial Chemotherapy|September 1, 1989
Determinants of efficacy and toxicity of aminoglycosidesH Mattie, W A Craig, J C PechèreThe Journal of Bone and Joint Surgery. American Volume|September 1, 1976
Compensating osteotomy at the base of the femoral neck for slipped capital femoral epiphysisW G Kramer, W A Craig, S NoelAntimicrobial Agents and Chemotherapy|September 22, 2010
In vivo pharmacodynamics of new lipopeptide MX-2401W A Craig, D R Andes, T StamstadPharmacotherapy|November 1, 1983
Netilmicin sulfate: a comparative evaluation of antimicrobial activity, pharmacokinetics, adverse reactions and clinical efficacyW A Craig, S Gudmundsson, R M ReichSchweizerische Medizinische Wochenschrift|January 15, 1983
[What does the minimal inhibitory concentration of an antibiotic hide from the clinician? Experimental examples]A U Gerber, C Feller-Segessenmann, W A CraigPageof 20